References
- Wiest T., Schwarz E., Enders C., Flechtenmacher C., Bosch F. X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002; 21: 1510–7
- Herrero R., Castellsague X., Pawlita M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772–83
- Gillison M. L. Human papillomavirus‐associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744–54
- Li W., Thompson C. H., Cossart Y. E., et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004; 26: 1–9
- Hobbs C. G., Sterne J. A., Bailey M., et al. Human papillomavirus and head and neck cancer: a systematic review and meta‐analysis. Clin Otolaryngol 2006; 31: 259–66
- El‐Mofty S. K., Patil S. Human papillomavirus (HPV)‐related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 339–45
- Gillison M. L., Koch W. M., Capone R. B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709–20
- Mellin H., Friesland S., Lewensohn R., Dalianis T., Munck‐Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000; 89: 300–4
- Klussmann J. P., Weissenborn S. J., Wieland U., et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001; 92: 2875–84
- Li W., Thompson C. H., Xin D., et al. Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 2003; 163: 2185–9
- Li W., Thompson C. H., O'Brien C. J., et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003; 106: 553–8
- Resnick R. M., Cornelissen M. T., Wright D. K., et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477–84
- de Roda Husman A. M., Walboomers J. M., van den Brule A. J., Meijer C. J., Snijders P. J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057–62
- Boxman I. L., Russell A., Mulder L. H., et al. Association between epidermodysplasia verruciformis‐associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol 2001; 117: 1108–12
- Forslund O., Antonsson A., Nordin P., Stenquist B., Hansson B. G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80: 2437–43
- Wieland U., Jurk S., Weissenborn S., et al. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000; 115: 396–401
- Rose B. R., Thompson C. H., Chantrill L. A., Tattersall M. H., Cossart Y. E. Prevalence and distribution of human papillomavirus type‐16 DNA in pelvic lymph nodes of patients with cervical cancer and in women with no history of cervical abnormality. Int J Cancer 1992; 52: 225–8
- Li W., Thompson C. H., Cossart Y. E., et al. The site of infection and ethnicity of the patient influence the biological pathways to HPV‐induced mucosal cancer. Mod Pathol 2004; 17: 1031–7
- Sano T., Oyama T., Kashiwabara K., Fukuda T., Nakajima T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998; 48: 580–5
- Klussmann J. P., Gultekin E., Weissenborn S. J., et al. Expression of p16 Protein Identifies a Distinct Entity of Tonsillar Carcinomas Associated with Human Papillomavirus. Am J Pathol 2003; 162: 747–53
- Andl T., Kahn T., Pfuhl A., et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998; 58: 5–13
- Wittekindt C., Gultekin E., Weissenborn S. J., et al. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv Otorhinolaryngol 2005; 62: 72–80
- Lukas J., Muller H., Bartkova J., et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994; 125: 625–38
- Mellin Dahlstrand H., Lindquist D., Bjornestal L., et al. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 2005; 25: 4375–83
- Weinberger P. M., Yu Z., Haffty B. G., et al. Molecular classification identifies a subset of human papillomavirus—associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736–47
- Smith E. M., Ritchie J. M., Summersgill K. F., et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766–72
- Pinbord J. J. R. P., Smith C. J., van der Waal I. Histological Typing of Cancer and Precancer of the Oral Mucosa. Springer, New York 1997, 2nd ed